Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Genfit S.A. GNFT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • FR • USD

SharesGrow Score
53/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
+45.3%

Insider Transactions — GNFT

No insider transactions data available for GNFT.

People Also View

EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
 HRMY
HRMY
Harmony Biosciences Holdings, Inc.
$29.29
+0.83%
 JANX
JANX
Janux Therapeutics, Inc.
$15.24
+2.28%
 KROS
KROS
Keros Therapeutics, Inc.
$11.55
+3.59%
 ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
 RZLT
RZLT
Rezolute, Inc.
$3.56
-1.36%
 FENC
FENC
Fennec Pharmaceuticals Inc.
$6.25
+5.40%
 MOLN
MOLN
Molecular Partners AG
$4.14
-1.66%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message